Combination of chemotherapy and immunotherapy of adoptive cell transfer with tumor infiltrating lymphocytes, followed by interleukin-2, is labor-intensive but a feasible therapy with a high response rate in treated patients.
Melanoma Research Foundation
Donate TodayEvery day the Melanoma Research Foundation works to make the fight against melanoma easier. Your donation will help us support patients, fund research and advocate for the melanoma community.
2023 Fighting Melanoma